1
|
Oh SC: Update of adjuvant chemotherapy for
resected gastric cancer. J Gastric Cancer. 12:3–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Schwarz RE and Smith DD: Clinical impact
of lymphadenectomy extent in resectable gastric cancer of advanced
stage. Ann Surg Oncol. 14:317–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
4
|
Rowinsky EK, Cazenave LA and Donehower RC:
Taxol: a novel investigational antimicrotubule agent. J Natl Cancer
Inst. 82:1247–1259. 1990. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mancuso A, Oudard S and Sternberg CN:
Effective chemotherapy for hormone-refractory prostate cancer
(HRPC): present status and perspectives with taxane-based
treatments. Crit Rev Oncol Hematol. 61:176–185. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Weiss RB, Donehower RC, Wiernik PH, Ohnuma
T, Gralla RJ, Trump DL, et al: Hypersensitivity reactions from
taxol. J Clin Oncol. 8:1263–1268. 1990.PubMed/NCBI
|
7
|
Akhlaghi SP, Saremi S, Ostad SN, Dinarvand
R and Atyabi F: Discriminated effects of thiolated chitosan-coated
pMMA paclitaxel-loaded nanoparticles on different normal and cancer
cell lines. Nanomedicine. 6:689–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo
J, Sha X and Fang X: Enhanced antitumor efficacy by
paclitaxel-loaded pluronic P123/F127 mixed micelles against
non-small cell lung cancer based on passive tumor targeting and
modulation of drug resistance. Eur J Pharm Biopharm. 75:341–353.
2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
de Britto D and Assis OBG: A novel method
for obtaining a quaternary salt of chitosan. Carbohydr Polym.
69:305–310. 2007.
|
10
|
Slütter B and Jiskoot W: Dual role of CpG
as immune modulator and physical crosslinker in ovalbumin loaded
N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination. J
Control Release. 148:117–121. 2010.PubMed/NCBI
|
11
|
Subbiah R, Ramalingam P, Ramasundaram S,
et al: N,N,N-trimethyl chitosan nanoparticles for controlled
intranasal delivery of HBV surface antigen. Carbohydr Polym.
89:1289–1297. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hamman JH, Stander M and Kotze AF: Effect
of the degree of quaternisation of N-trimethyl chitosan chloride on
absorption enhancement: in vivo evaluation in rat nasal epithelia.
Int J Pharm. 232:235–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
de Britto D, Forato LA and Assis OBG:
Determination of the average degree of quaternization of
N,N,N-trimethylchitosan by solid state C-13 NMR. Carbohydr Polym.
74:86–91. 2008.
|
14
|
de Moura MR, Aouada FA, Avena-Bustillos
RJ, McHugh TH, Krochta JM and Mattoso LHC: Improved barrier and
mechanical properties of novel hydroxypropyl methylcellulose edible
films with chitosan/tripolyphosphate nanoparticles. J Food Eng.
92:448–453. 2009.
|
15
|
de Britto D, de Moura MR, Aouada FA,
Mattoso LHC and Assis OBG: N,N,N-trimethyl chitosan nanoparticles
as a vitamin carrier system. Food Hydrocoll. 27:487–493. 2012.
|
16
|
Bhumkar DR and Pokharkar VB: Studies on
effect of pH on cross-linking of chitosan with sodium
tripolyphosphate: a technical note. AAPS PharmSciTech. 7:E502006.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Chen F, Zhang ZR and Huang Y: Evaluation
and modification of N-trimethyl chitosan chloride nanoparticles as
protein carriers. Int J Pharm. 336:166–173. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gan Q and Wang T: Chitosan nanoparticle as
protein delivery carrier - systematic examination of fabrication
conditions for efficient loading and release. Colloids Surf B
Biointerfaces. 59:24–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Qi L, Xu Z, Jiang X, Hu C and Zou X:
Preparation and antibacterial activity of chitosan nanoparticles.
Carbohydr Res. 339:2693–2700. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Davda J and Labhasetwar V:
Characterization of nanoparticle uptake by endothelial cells. Int J
Pharm. 233:51–59. 2002. View Article : Google Scholar
|
21
|
Yu B, Zhang Y, Zheng W, Fan C and Chen T:
Positive surface charge enhances selective cellular uptake and
anticancer efficacy of selenium nanoparticles. Inorg Chem.
51:8956–8963. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ganesh T, Yang C, Norris A, et al:
Evaluation of the tubulin-bound paclitaxel conformation: synthesis,
biology, and SAR studies of C-4 to C-3′ bridged paclitaxel
analogues. J Med Chem. 50:713–725. 2007.PubMed/NCBI
|
23
|
Sharma AK, Zhang L, Li S, Kelly DL,
Alakhov VY, Batrakova EV and Kabanov AV: Prevention of MDR
development in leukemia cells by micelle-forming polymeric
surfactant. J Control Release. 131:220–227. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Guo DD, Moon HS, Arote R, Seo JH, Quan JS,
Choi YJ and Cho CS: Enhanced anticancer effect of conjugated
linoleic acid by conjugation with Pluronic F127 on MCF-7 breast
cancer cells. Cancer Lett. 254:244–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Guo DD, Xu CX, Quan JS, Song CK, Jin H,
Kim DD, Choi YJ, Cho MH and Cho CS: Synergistic anti-tumor activity
of paclitaxel-incorporated conjugated linoleic acid-coupled
poloxamer thermosensitive hydrogel in vitro and in vivo.
Biomaterials. 30:4777–4785. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Ahmed F, Pakunlu RI, Brannan A, Bates F,
Minko T and Discher DE: Biodegradable polymersomes loaded with both
paclitaxel and doxorubicin permeate and shrink tumors, inducing
apoptosis in proportion to accumulated drug. J Control Release.
116:150–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Ng SSW, Tsao MS, Chow S and Hedley DW:
Inhibition of phosphatidylinositide 3-kinase enhances
gemcitabine-induced apoptosis in human pancreatic cancer cells.
Cancer Res. 60:5451–5455. 2000.PubMed/NCBI
|
28
|
Kim K, Kim JH, Park H, Kim YS, Park K, Nam
H, et al: Tumor-homing multifunctional nanoparticles for cancer
theragnosis: simultaneous diagnosis, drug delivery, and therapeutic
monitoring. J Control Release. 146:219–227. 2010. View Article : Google Scholar
|
29
|
Zhang L, He Y, Ma G, Song C and Sun H:
Paclitaxel-loaded polymeric micelles based on
poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone)
triblock copolymers: in vitro and in vivo evaluation. Nanomedicine.
8:925–934. 2012.
|
30
|
Xiao K, Luo J, Fowler WL, Li Y, Lee JS,
Xing L, Cheng RH, Wang L and Lam KS: A self-assembling nanoparticle
for paclitaxel delivery in ovarian cancer. Biomaterials.
30:6006–6016. 2009. View Article : Google Scholar : PubMed/NCBI
|